Literature DB >> 31256048

Ischaemic stroke as the initial manifestation of systemic amyloidosis.

Patrícia Marques1, José Beato-Coelho1, João Durães1, Argemiro Geraldo1.   

Abstract

A previously healthy 54-year-old woman was admitted to the stroke unit with an acute ischaemic stroke attributed to atrial fibrillation newly diagnosed at the emergency room. Nevertheless, preliminary investigation on stroke aetiology revealed incidental hypoalbuminaemia in the context of nephrotic syndrome, while clinically, the patient developed progressive signs of cardiac failure raising the suspicion of an underlying disorder. Systemic amyloidosis was histologically confirmed a few weeks after hospital admission. The rare presentation and non-specific symptom constellation contributed to delayed institution of the appropriated treatment regimen at a point where multiorganic involvement was irreversible leading to death only 2 months after the first manifestation. The presented case reminds us of the importance of always keeping in mind this rarer cause of ischaemic stroke since an early diagnosis remains the key to a more hopeful prognosis. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arrhythmias; nephrotic syndrome; stroke

Mesh:

Year:  2019        PMID: 31256048      PMCID: PMC6605910          DOI: 10.1136/bcr-2018-228979

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Authors:  Blaithnead Murtagh; Stephen C Hammill; Morie A Gertz; Robert A Kyle; A Jamil Tajik; Martha Grogan
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

Review 2.  What is new in diagnosis and management of light chain amyloidosis?

Authors:  Giovanni Palladini; Giampaolo Merlini
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

3.  Guidelines on the diagnosis and investigation of AL amyloidosis.

Authors:  Julian D Gillmore; Ashutosh Wechalekar; Jenny Bird; Jamie Cavenagh; Stephen Hawkins; Majid Kazmi; Helen J Lachmann; Philip N Hawkins; Guy Pratt
Journal:  Br J Haematol       Date:  2014-10-14       Impact factor: 6.998

4.  Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry.

Authors:  Anna Bersano; Hugh Stephen Markus; Silvana Quaglini; Eloisa Arbustini; Silvia Lanfranconi; Giuseppe Micieli; Giorgio B Boncoraglio; Franco Taroni; Cinzia Gellera; Silvia Baratta; Silvana Penco; Lorena Mosca; Maurizia Grasso; Paola Carrera; Maurizio Ferrari; Cristina Cereda; Gaetano Grieco; Stefania Corti; Dario Ronchi; Maria Teresa Bassi; Laura Obici; Eugenio A Parati; Alessando Pezzini; Maria Luisa De Lodovici; Elena P Verrengia; Giorgio Bono; Francesca Mazucchelli; Davide Zarcone; Maria Vittoria Calloni; Patrizia Perrone; Bianca Maria Bordo; Antonio Colombo; Alessandro Padovani; Anna Cavallini; Simone Beretta; Carlo Ferrarese; Cristina Motto; Elio Agostoni; Graziella Molini; Francesco Sasanelli; Manuel Corato; Simona Marcheselli; Maria Sessa; Giancarlo Comi; Nicoletta Checcarelli; Mario Guidotti; Davide Uccellini; Erminio Capitani; Lucia Tancredi; Marco Arnaboldi; Barbara Incorvaia; Carlo Sebastiano Tadeo; Laura Fusi; Giampiero Grampa; Giampaolo Merlini; Nadia Trobia; Giacomo Pietro Comi; Massimiliano Braga; Paolo Vitali; Pierluigi Baron; Caspar Grond-Ginsbach; Livia Candelise
Journal:  Stroke       Date:  2016-05-31       Impact factor: 7.914

Review 5.  Systemic amyloidosis.

Authors:  Ashutosh D Wechalekar; Julian D Gillmore; Philip N Hawkins
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

6.  Intracardiac thrombosis and embolism in patients with cardiac amyloidosis.

Authors:  DaLi Feng; William D Edwards; Jae K Oh; Krishnaswamy Chandrasekaran; Martha Grogan; Matthew W Martinez; Imran S Syed; Imran I Syed; Deborah A Hughes; John A Lust; Allan S Jaffe; Morie A Gertz; Kyle W Klarich
Journal:  Circulation       Date:  2007-11-05       Impact factor: 29.690

Review 7.  Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement.

Authors:  Angela Dispenzieri; Francis Buadi; Shaji K Kumar; Craig B Reeder; Tamur Sher; Martha Q Lacy; Robert A Kyle; Joseph R Mikhael; Vivek Roy; Nelson Leung; Martha Grogan; Prashant Kapoor; John A Lust; David Dingli; Ronald S Go; Yi Lisa Hwa; Suzanne R Hayman; Rafael Fonseca; Sikander Ailawadhi; P Leif Bergsagel; Ascher Chanan-Khan; S Vincent Rajkumar; Stephen J Russell; Keith Stewart; Steven R Zeldenrust; Morie A Gertz
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

8.  Diagnostic approach to cardiac amyloidosis: A case report.

Authors:  Andreia Fernandes; Francisca Caetano; Inês Almeida; Luís Paiva; Pedro Gomes; Paula Mota; Joana Trigo; Ana Botelho; Maria do Carmo Cachulo; Joana Alves; Luís Francisco; António Leitão Marques
Journal:  Rev Port Cardiol       Date:  2016-04-23       Impact factor: 1.374

9.  Primary systemic amyloidosis with ischemic stroke as a presenting complication.

Authors:  Alexander Y Zubkov; Alejandro A Rabinstein; Angela Dispenzieri; Eelco F M Wijdicks
Journal:  Neurology       Date:  2007-09-11       Impact factor: 9.910

10.  A case of cerebral hyperperfusion following spontaneous recanalization of occluded middle cerebral artery: Reperfusion injury or true cerebral hyperperfusion syndrome?

Authors:  Ziqi Xu; Jiajia Zhou; Hui Liang; Benyan Luo; Ping Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

View more
  1 in total

1.  Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean Patients.

Authors:  Rishika Banydeen; Aissatou Signate; Tuan-Huy Tran; Astrid Monfort; Remi Neviere; Jocelyn Inamo
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.